Skip to main content
SpringerLink
Log in

Biomedical HIV Protection Among Gay and Bisexual Men Who Use Crystal Methamphetamine

AIDS and Behavior volume 24, pages 1400–1413 (2020)Cite this article

Abstract

Use of crystal methamphetamine (crystal) among gay and bisexual men (GBM) has been associated with condomless anal intercourse with casual partners (CLAIC) and HIV infection. Pre-exposure prophylaxis (PrEP) and undetectable viral load (UVL) are important biomedical HIV prevention strategies. We investigate the relationship between crystal use and HIV sexual risk behaviours in the context of PrEP and UVL. In 2018, 1367 GBM provided details about crystal use and HIV prevention strategies. Binary logistic regression was used to estimate associations between crystal use and behaviour. Recent crystal use was independently associated with greater social engagement with gay men and having more sexual partners. Crystal use was also independently associated with use of PrEP and UVL among GBM who engaged in CLAIC. Although GBM who used crystal were more likely to have engaged in CLAIC, they were also more likely to use biomedical HIV prevention which mitigates against the risks of HIV infection.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Jin F, Crawford J, Prestage GP, et al. Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS. 2009;23(2):243–52. https://doi.org/10.1097/QAD.0b013e32831fb51a.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Piyaraj P, van Griensven F, Holtz TH, et al. The finding of casual sex partners on the internet, methamphetamine use for sexual pleasure, and incidence of HIV infection among men who have sex with men in Bangkok, Thailand: an observational cohort study. Lancet HIV. 2018;5(7):e379–89.

    PubMed  PubMed Central  Google Scholar 

  3. Plankey MW, Ostrow DG, Stall R, et al. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. JAIDS. 2007;45(1):85.

    CAS  PubMed  Google Scholar 

  4. Prestage G, Jin F, Kippax S, et al. Use of illicit drugs and erectile dysfunction medications and subsequent HIV infection among gay men in Sydney, Australia. J Sex Med. 2009;6(8):2311–20. https://doi.org/10.1111/j.1743-6109.2009.01323.x.

    Article  PubMed  Google Scholar 

  5. Jin F, Jansson J, Law M, et al. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS. 2010;24(6):907–13. https://doi.org/10.1097/QAD.0b013e3283372d90.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New Engl J Med. 2010;363(27):2587–99. https://doi.org/10.1056/NEJMoa1011205.

    Article  CAS  PubMed  Google Scholar 

  7. McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60. https://doi.org/10.1016/s0140-6736(15)00056-2.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Molina J-M, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New Eng J Med. 2015;373(23):2237–46. https://doi.org/10.1056/NEJMoa1506273.

    Article  CAS  PubMed  Google Scholar 

  9. Bavinton BR, Pinto AN, Phanuphak N, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018;5(8):e438–47. https://doi.org/10.1016/s2352-3018(18)30132-2.

    Article  PubMed  Google Scholar 

  10. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. New Eng J Med. 2011;365(6):493–505. https://doi.org/10.1056/NEJMoa1105243.

    Article  CAS  PubMed  Google Scholar 

  11. Rodger A, Cambiano V, Bruun T, et al. Risk of HIV transmission through condomless sex in MSM couples with suppressive ART: The PARTNER2 Study extended results in gay men. Paper presented at: Journal of the International AIDS Society 2018.

  12. Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316(2):171–81. https://doi.org/10.1001/jama.2016.5148.

    Article  PubMed  Google Scholar 

  13. Roxburgh A, Lea T, de Wit J, Degenhardt L. Sexual identity and prevalence of alcohol and other drug use among Australians in the general population. Int J Drug Policy. 2016;28:76–82. https://doi.org/10.1016/j.drugpo.2015.11.005.

    Article  PubMed  Google Scholar 

  14. Broady T, Mao L, Bavinton B, et al. Gay Community Periodic Survey: Adelaide 2018. Sydney: Centre for Social Research in Health, UNSW Australia. 2019. http://unsworks.unsw.edu.au/fapi/datastream/unsworks:58353/binbe9ddc0f-f25b-43fa-a05c-3e07887bf418?view=true. Accessed 19 April 2019.

  15. Lee E, Mao L, Broady T, et al. Gay Community Periodic Survey: Melbourne 2018. Sydney: Centre for Social Research in Health, UNSW Australia. 2018. http://unsworks.unsw.edu.au/fapi/datastream/unsworks:50970/bin35d6913b-dbd9-48d5-bf80-a0ace96e3dc4?view=true&xy=01. Accessed 19 April 2019.

  16. Broady T, Lee E, Mao L, et al. Gay Community Periodic Survey: Queensland 2018. Sydney: Centre for Social Research in Health, UNSW Australia. 2019. http://unsworks.unsw.edu.au/fapi/datastream/unsworks:57313/bin9693fa2d-d2ae-4831-b00d-b102885f0e84?view=true. Accessed 19 April 2019.

  17. Broady T, Mao L, Lee E, et al. Gay Community Periodic Survey: Sydney 2018. Sydney: Centre for Social Research in Health, UNSW Australia. 2018. http://unsworks.unsw.edu.au/fapi/datastream/unsworks:52117/binae80f831-8458-4fec-8c2b-1f7ba7402409?view=true. Accessed 19 April 2019.

  18. Broady T, Mao L, Lee E, et al. Gay Community Periodic Survey: Tasmania 2018. Sydney: Centre for Social Research in Health, UNSW Australia. 2019. http://unsworks.unsw.edu.au/fapi/datastream/unsworks:55228/bin2d640fa7-71b3-4372-bb3b-1fd49f94494f?view=true. Accessed 19 April 2019.

  19. Halkitis PN, Fischgrund BN, Parsons JT. Explanations for methamphetamine use among gay and bisexual men in New York City. Subst Use Misuse. 2005;40(9–10):1331–45.

    PubMed  Google Scholar 

  20. Semple SJ, Patterson TL, Grant I. Motivations associated with methamphetamine use among HIV men who have sex with men. J Subst Abuse Treat. 2002;22(3):149–56.

    PubMed  Google Scholar 

  21. Weatherburn P, Hickson F, Reid D, Torres-Rueda S, Bourne A. Motivations and values associated with combining sex and illicit drugs (‘chemsex’) among gay men in South London: findings from a qualitative study. Sex Transm Infect. 2017;93(3):203–6.

    CAS  PubMed  Google Scholar 

  22. Bourne A, Reid D, Hickson F, Torres-Rueda S, Weatherburn P. Illicit drug use in sexual settings (‘chemsex’) and HIV/STI transmission risk behaviour among gay men in South London: findings from a qualitative study. Sex Transm Infect. 2015;91(8):564–8.

    CAS  PubMed  Google Scholar 

  23. Stuart D. Chemsex: origins of the word, a history of the phenomenon and a respect to the culture. Drugs Alcohol Today. 2019;19(1):3–10. https://doi.org/10.1108/DAT-10-2018-0058.

    Article  Google Scholar 

  24. Lea T, Mao L, Hopwood M, et al. Methamphetamine use among gay and bisexual men in Australia: trends in recent and regular use from the Gay Community Periodic Surveys. Int J Drug Policy. 2016;29:66–72.

    PubMed  Google Scholar 

  25. Prestage G, Fogarty AS, Rawstorne P, et al. Use of illicit drugs among gay men living with HIV in Sydney. AIDS. 2007;21:49–55.

    Google Scholar 

  26. Saxton P, Newcombe D, Ahmed A, Dickson N, Hughes A. Illicit drug use among New Zealand gay and bisexual men: prevalence and association with sexual health behaviours. Drug Alcohol Rev. 2018;37(2):180–7.

    PubMed  Google Scholar 

  27. Vosburgh HW, Mansergh G, Sullivan PS, Purcell DW. A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men. AIDS Behav. 2012;16(6):1394–410.

    PubMed  Google Scholar 

  28. Hammoud MA, Vaccher S, Jin F, et al. HIV pre-exposure prophylaxis (PrEP) uptake among gay and bisexual men in australia and factors associated with the nonuse of PrEP among eligible men: results from a prospective cohort Study. JAIDS. 2019;81(3):e73–84.

    PubMed  Google Scholar 

  29. Holt M. Gay Men’s HIV risk reduction practices: the influence of epistemic communities in hiv social and behavioral research. AIDS Educ Prev. 2014;26(3):214–23. https://doi.org/10.1521/aeap.2014.26.3.214.

    Article  PubMed  Google Scholar 

  30. Kippax S, Crawford J, Davis M, Rodden P, Dowsett G. Sustaining safe sex: a longitudinal study of a sample of homosexual men. AIDS. 1993;7(2):257–63.

    CAS  PubMed  Google Scholar 

  31. Bryant J, Rance J, Treloar C. Annual Report of Trends in Behaviour 2019: Viral Hepatitis in Australia. Sydney: Centre for Social Research in Health, UNSW Sydney. 2019. http://unsworks.unsw.edu.au/fapi/datastream/unsworks:59969/binc1fe6e52-2310-4461-b820-a36c94de5d4f?view=true&xy=01. Accessed 7 June 2019.

  32. Southgate E, Hopwood M. The role of folk pharmacology and lay experts in harm reduction: sydney gay drug using networks. Int J Drug Policy. 2001;12(4):321–35.

    Google Scholar 

  33. NPS MedicineWise. PrEP on the PBS: an opportunity in HIV prevention. 2018. https://www.nps.org.au/news/pr-ep-on-the-pbs-an-opportunity-in-hiv-prevention. Accessed 7 June 2019.

  34. Wright E, Grulich A, Roy K, et al. Australasian Society for HIV, viral hepatitis and sexual health medicine HIV pre-exposure prophylaxis: clinical guidelines. J Virus Erad. 2017;3(3):168–84.

    PubMed  PubMed Central  Google Scholar 

  35. Wright E, Grulich A, Roy K, et al. Australasian society for HIV, viral hepatitis and sexual health medicine HIV pre-exposure prophylaxis: clinical guidelines. J Virus Erad. 2018;4(2):143.

    PubMed  PubMed Central  Google Scholar 

  36. Holt M, Lea T, Mao L, et al. Community-level changes in condom use and uptake of HIV pre-exposure prophylaxis by gay and bisexual men in Melbourne and Sydney, Australia: results of repeated behavioural surveillance in 2013–17. Lancet HIV. 2018;5(8):e448–56.

    PubMed  Google Scholar 

  37. Keen P, Gray RT, Telfer B, et al. The 2016 HIV diagnosis and care cascade in New South Wales, Australia: meeting the UNAIDS 90-90-90 targets. J Int AIDS Soc. 2018;21(4):e25109. https://doi.org/10.1002/jia2.25109.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2018. Sydney: Kirby Institute, UNSW Sydney 2018. https://kirby.unsw.edu.au/sites/default/files/kirby/report/KI_Annual-Surveillance-Report-2018.pdf. Accessed 28 June 2019.

  39. Hammoud MA, Vaccher S, Jin F, et al. The new MTV generation: using methamphetamine, Truvada™, and Viagra™ to enhance sex and stay safe. Int J Drug Policy. 2018;55:197–204.

    PubMed  Google Scholar 

  40. Jin F, Prestage GP, Mao L, et al. “Any condomless anal intercourse” is no longer an accurate measure of HIV sexual risk behavior in gay and other men who have sex with men. Front Immunol. 2015;6:86.

    PubMed  PubMed Central  Google Scholar 

  41. Hammoud MA, Jin F, Degenhardt L, et al. Following Lives Undergoing Change (Flux) study: implementation and baseline prevalence of drug use in an online cohort study of gay and bisexual men in Australia. Int J Drug Policy. 2017;41:41–50. https://doi.org/10.1016/j.drugpo.2016.11.012.

    Article  PubMed  Google Scholar 

  42. Halkitis PN, Parsons JT. Recreational drug use and HIV-risk sexual behavior among men frequenting gay social venues. J Gay Lesbian Soc Serv. 2002;14(4):19–38.

    Google Scholar 

  43. Bavinton BR, Duncan D, Grierson J, et al. The meaning of ‘regular partner’in HIV research among gay and bisexual men: implications of an Australian cross-sectional survey. AIDS Behav. 2016;20(8):1777–84.

    PubMed  Google Scholar 

  44. Kippax S, Campbell D, Van de Ven P, et al. Cultures of sexual adventurism as markers of HIV seroconversion: a case control study in a cohort of Sydney gay men. AIDS Care. 1998;10(6):677–88.

    CAS  PubMed  Google Scholar 

  45. Löwe B, Decker O, Müller S, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46(3):266–74.

    PubMed  Google Scholar 

  46. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.

    PubMed  Google Scholar 

  47. Chagas MHN, Tumas V, Rodrigues GR, et al. Validation and internal consistency of Patient Health Questionnaire-9 for major depression in Parkinson’s disease. Age Ageing. 2013;42(5):645–9.

    PubMed  Google Scholar 

  48. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Inter Med. 2001;16(9):606–13.

    CAS  Google Scholar 

  49. Rosenberg M. Society and the adolescent self-image. Princeton: Princeton University Press; 2015.

    Google Scholar 

  50. Robins RW, Hendin HM, Trzesniewski KH. Measuring global self-esteem: construct validation of a single-item measure and the Rosenberg Self-Esteem Scale. Pers Soc Psychol Bull. 2001;27(2):151–61.

    Google Scholar 

  51. Gaither GA, Sellbom M. The sexual sensation seeking scale: reliablity and validity within a heterosexual college student sample. J Pers Assess. 2003;81(2):157–67.

    PubMed  Google Scholar 

  52. Kalichman SC, Rompa D. Sexual sensation seeking and sexual compulsivity scales: validity, and predicting HIV risk behavior. J Pers Assess. 1995;65(3):586–601.

    CAS  PubMed  Google Scholar 

  53. Vaccher SJ, Gianacas C, Templeton DJ, et al. Baseline preferences for daily, event-driven, or periodic HIV pre-exposure prophylaxis among gay and bisexual men in the PRELUDE demonstration project. Front Public Health. 2017;5:341.

    PubMed  PubMed Central  Google Scholar 

  54. Cochran SD, Ackerman D, Mays VM, Ross MW. Prevalence of non-medical drug use and dependence among homosexually active men and women in the US population. Addiction. 2004;99(8):989–98. https://doi.org/10.1111/j.1360-0443.2004.00759.x.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Roux P, Fressard L, Suzan-Monti M, et al. Is on-demand HIV pre-exposure prophylaxis a suitable tool for men who have sex with men who practice chemsex? Results from a substudy of the ANRS-IPERGAY trial. JAIDS. 2018;79(2):e69–75.

    PubMed  Google Scholar 

  56. Prestage G, Maher L, Grulich A, et al. Brief report: changes in behavior after PrEP initiation among Australian Gay and Bisexual Men. JAIDS. 2019;81(1):52–6.

    PubMed  Google Scholar 

  57. Kirby Institute. National HIV Quarterly Report: Q4 2018. National HIV Quarterly Report: Q4 2018. 2019. https://kirby.unsw.edu.au/sites/default/files/kirby/report/National-HIV-Quarterly-Report_2018-Q4.pdf. Accessed 8 July 2019.

  58. Murphy D. Off-label: the changing boundaries of prevention. HIV Aust. 2015;13(2):25.

    Google Scholar 

  59. Kippax S, Race K. Sustaining safe practice: twenty years on. Soc Sci Med. 2003;57(1):1–12. https://doi.org/10.1016/s0277-9536(02)00303-9.

    Article  PubMed  Google Scholar 

  60. Zablotska IB, Holt M, Prestage G. Changes in gay men’s participation in gay community life: implications for HIV surveillance and research. AIDS Behav. 2012;16(3):669–75.

    PubMed  Google Scholar 

  61. Isaiah Green A, Halkitis PN. Crystal methamphetamine and sexual sociality in an urban gay subculture: an elective affinity. Cult Health Sex. 2006;8(4):317–33.

    Google Scholar 

  62. Prestage G, Hammoud M, Jin F, et al. Mental health, drug use and sexual risk behavior among gay and bisexual men. Int J Drug Policy. 2018;55:169–79.

    PubMed  Google Scholar 

  63. Mao L, Kidd MR, Rogers G, et al. Social factors associated with Major Depressive Disorder in homosexually active, gay men attending general practices in urban Australia. Aust NZ J Public Health. 2009;33(1):83–6. https://doi.org/10.1111/j.1753-6405.2009.00344.x.

    Article  Google Scholar 

  64. McLaren S, Jude B, McLachlan AJ. Sense of belonging to the general and Gay communities as predictors of depression among Australian Gay Men. Int J Men’s Health. 2008;7(1):90–9.

    Google Scholar 

  65. Prestage GP, Hudson J, Jin F, et al. Testing for HIV and sexually transmissible infections within a mainly online sample of gay men who engage in group sex. Sex Transm Infect. 2009;85(1):70–4.

    CAS  PubMed  Google Scholar 

  66. Grulich AE, Guy R, Amin J, et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5(11):e629–37.

    PubMed  Google Scholar 

  67. Holt M, Lea T, Mao L, et al. Adapting behavioural surveillance to antiretroviral-based HIV prevention: reviewing and anticipating trends in the Australian Gay Community Periodic Surveys. Sex Health. 2017;14(1):72–9. https://doi.org/10.1071/sh16072.

    Article  PubMed  Google Scholar 

  68. Girometti N, Gutierrez A, Nwokolo N, McOwan A, Whitlock G. High HIV incidence in men who have sex with men following an early syphilis diagnosis: is there room for pre-exposure prophylaxis as a prevention strategy? Sex Transm Infect. 2017;93(5):320–2.

    PubMed  Google Scholar 

  69. Sewell J, Miltz A, Lampe FC, et al. Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics. Int J Drug Policy. 2017;43:33–43.

    PubMed  Google Scholar 

Download references

Acknowledgements

The study team would like to thank all participants for their continued participation in the Flux Study.

Funding

This work was funded by the Australian Research Council (ARC). ARC grant number: DP140102483. The Kirby Institute receive funding from the Australian Government Department of Health. Lisa Maher is supported by a National Health and Medical Research Council Senior Research Fellowship. Peter Saxton was supported by a New Zealand AIDS Foundation Fellowship. Toby Lea is supported by an Alexander von Humboldt Foundation Research Fellowship. In 2018, this study was partly funded by the Gilead Australia Fellowship: Research Grants Program. Funders had no input in the data collection, analysis, interpretation, or presentation of any findings.

Author information

Authors and Affiliations

  1. HIV Epidemiology and Prevention Program, Kirby Institute, UNSW Sydney, Level 6, Wallace Wurth Building, Kensington, Sydney, NSW, 2052, Australia

    Mohamed A. Hammoud, Fengyi Jin, Stefanie Vaccher & Garrett Prestage

  2. Viral Hepatitis Epidemiology and Prevention Program, Kirby Institute, UNSW Sydney, Level 6, Wallace Wurth Building, Kensington, Sydney, NSW, 2052, Australia

    Lisa Maher

  3. Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Building NR6, Bundoora, VIC, 3086, Australia

    Adam Bourne

  4. Public Health Interventions Research Group, Kirby Institute, UNSW Sydney, Level 6, Wallace Wurth Building, Sydney, NSW, 2052, Australia

    Bridget Haire

  5. Department of Social and Community Health, School of Population Health, University of Auckland, Building 730, Tamaki Campus, 261 Morrin Road, St Johns, Auckland, 1072, New Zealand

    Peter Saxton

  6. German Institute for Addiction and Prevention Research, Catholic University of Applied Sciences, Konrad-Adenauer-Ufer 79-81, 50668, Cologne, Germany

    Toby Lea

  7. Centre for Social Research in Health, UNSW Sydney, John Goodsell Building, UNSW, Sydney, NSW, 2052, Australia

    Toby Lea

  8. National Drug and Alcohol Research Centre, UNSW Sydney, 22 – 32 King Street, Randwick, NSW, 2031, Australia

    Louisa Degenhardt

Authors
  1. Mohamed A. Hammoud
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fengyi Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lisa Maher
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Adam Bourne
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bridget Haire
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter Saxton
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stefanie Vaccher
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Toby Lea
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Louisa Degenhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Garrett Prestage
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Mohamed A. Hammoud. The first draft of the manuscript was written by Mohamed A. Hammoud and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Mohamed A. Hammoud.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hammoud, M.A., Jin, F., Maher, L. et al. Biomedical HIV Protection Among Gay and Bisexual Men Who Use Crystal Methamphetamine. AIDS Behav 24, 1400–1413 (2020). https://doi.org/10.1007/s10461-019-02739-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-019-02739-7

Keywords

search

Navigation